Vogenx, Inc. (VOGX) Debt Components
- 2026-06-30: Convertible Notes Payable, CurrentUSD $867.70K; Debt Instrument, Face AmountUSD (m); Debt Instrument, Interest Rate, Increase (Decrease)pure (m); Debt Instrument, Interest Rate, Stated Percentagepure (m).
- 2025-12-31: Convertible Notes Payable, CurrentUSD $816.30K; Debt Instrument, Face AmountUSD (m); Debt Instrument, Interest Rate, Increase (Decrease)pure (m); Debt Instrument, Interest Rate, Stated Percentagepure (m).
- 2025-12-08: Convertible Notes Payable, CurrentUSD (m); Debt Instrument, Face AmountUSD $750.00K; Debt Instrument, Interest Rate, Increase (Decrease)pure 18.00%; Debt Instrument, Interest Rate, Stated Percentagepure 12.00%.
Vogenx, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Debt Instrument, Face Amount USD | Debt Instrument, Interest Rate, Increase (Decrease) pure | Debt Instrument, Interest Rate, Stated Percentage pure |
|---|---|---|---|---|
| 2026-06-30 | $867.70K | (m) | (m) | (m) |
| 2025-12-31 | $816.30K | (m) | (m) | (m) |
| 2025-12-08 | (m) | $750.00K | 18.00% | 12.00% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |